Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Justesa Química is a leading Spanish pharmaceutical company specializing in the development and manufacture of Active Pharmaceutical Ingredients (APIs) for diagnostic imaging. With over 70 years of experience, the company is a global reference in the production of iodinated contrast media for X-ray and CT scans, as well as gadolinium-based agents for MRI. Headquartered in Madrid, it operates a high-capacity manufacturing facility in Coslada that adheres to international GMP standards and exports to more than 40 countries. In 2024, the company was acquired by Aenova, a global CDMO, to strengthen its portfolio in the specialized imaging market. The company's expertise lies in complex chemical synthesis and large-scale industrial production of high-purity contrast agents.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Justesa Química.